PROFORMANT Contact Us
Company Services Experience Resources Partners News Site Map
Headlines
Announcements
Events
Industry Insight
Media Coverage

© 2001-2005 PROFORMANT, Inc.
All rights reserved.

Announcements

CAPITAL MANAGEMENT CONSULTING, INC. CHANGES CORPORATE NAME TO PROFORMANT, INC.

PROFORMANT name change communicates the company’s singular focus on biomedical corporate development.

Framingham, MA, July 30, 2001 — Capital Management Consulting, Inc. announced today that the Company's corporate name will change from Capital Management Consulting, Inc. to PROFORMANT, Inc.

“The name PROFORMANT is indicative of the company’s success in forecasting value creation,” said Joseph Kozikowski, M.D., Chairman and Managing Partner of PROFORMANT.

PROFORMANT’s professional service products address the biomedical corporate development business processes of strategic diligence, pipeline commercialization, portfolio architecture, and enterprise planning.

About PROFORMANT, Inc.

PROFORMANT delivers expertise and strategic consulting that enables pharmaceutical, biotechnology, medical device, and diagnostics companies to achieve new milestones of growth, competitive advantage, and value.

Visit PROFORMANT online at www.proformant.com

About Capital Management Consulting, Inc.

Capital Management Consulting develops biomedical companies with complete, end-to-end professional services solutions. Capital’s business development solutions, reaching from technology valuation, venture creation, and product portfolio analysis to licensing, M&A, and restructuring advisory services, have addressed more than $30B of equity value. Capital’s clinical development solutions, ranging from development planning and trial design to turnkey execution of all external development and registration operations, have resulted in accelerated approvals and launches of numerous products.

For further information, please contact:

Danielle LeBon
Communications Manager
PROFORMANT, Inc.
dlebon@proformant.com
508.872.2725 x104
(Framingham, MA)


PROFORMANT publishes its Pulmonary Biopharmaceutical Outlook. more


Download Brochure
PROFORMANT Privacy Policy Disclaimer